Detection of Transferrin Oxidative Modification In vitro and In vivo by Mass Spectrometry. Hereditary Hemochromatosis is a Model
Article Sidebar
Main Article Content
Abstract
Hereditary Hemochromatosis (HH) is an inherited recessive autosomal disorder characterized by the accumulation of excess iron. When iron-binding proteins become saturated, concentrations of free or Non-transferrin-bound iron (NTBI) rise, a condition thought to be responsible for the adverse effects associated with HH. To investigate whether disturbing iron homeostasis plays a role in free radical injury in HH, protein carbonyls were found to be 1-7 times higher in patients with HH than in controls, with the greatest increases observed in untreated HH patients with high ferritin and > 90% transferrin saturation with iron. An unpaired t-test revealed a p value of 0.0278 (p < 0.05), which is considered statistically significant.
In vitro oxidation of transferrin standards with hydrogen peroxide and excess iron, followed by immobilized trypsin digestion (Poroszyme), high-resolution LC-MS/MS analysis (Q-TOF Ultima, Waters), and MS/MS data processing (PEAKS, Bioinformatics Solution), identified several tryptic peptides containing oxidized Methionine (Met), Tryptophan (Trp), and Histidine (His) residues. Using the same methodology, oxidized residues were subsequently detected in transferrin isolated from plasma samples of patients severely affected by HH. Comparison of MS/MS spectra of In vitro oxidized samples with the most fragment ion peaks in common with oxidized peptide MS/MS spectra from patient samples revealed a strong correlation between the two. These data show that elevated NTBI may be involved in the oxidative modification of transferrin and that such modifications may play a significant role in the pathophysiology of HH.
Article Details
Copyright (c) 2025 Ahmed M, et al.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Van Campenhout A, Van Campenhout C, Lagrou A, Keenoy BM. Iron-induced oxidative stress in hemodialysis patients: A pilot study on the impact of diabetes. Biometals. 2008;21(1):159–70. Available from: https://doi.org/10.1007/s10534-007-9104-9
Jakeman A, Thompson T, McHattie J, Lehotay DC. Sensitive method for nontransferrin-bound iron quantification by graphite furnace atomic absorption spectrometry. Clin Biochem. 2001 Feb;34(1):43–7. Available from: https://doi.org/10.1016/s0009-9120(00)00194-6
Rudeck M, Volk T, Sitte N, Grune T. Ferritin oxidation In vitro: Implication of iron release and degradation by the 20S proteasome. IUBMB Life. 2000;49(6):451–6. Available from: https://doi.org/10.1080/152165400410317
Conrad C, Marshall P, Malakowsky C. Oxidized proteins in Alzheimer’s Plasma. Biochem Biophys Res Commun. 2000;275(2):678–81. Available from: https://doi.org/10.1006/bbrc.2000.3356
Chahine JM, Parkdman R, Abdalla F. A mechanism for iron uptake by transferrin. Eur J Biochem. 1996;236(3):922–31. Available from: https://doi.org/10.1111/j.1432-1033.1996.00922.x
Chahine JM, Parkdman R, Abdalla F. Transferrin as a mixed chelate-protein ternary complex involved in iron intake by serum-transferrin in vitro. J Mol Biol. 1999;293(5):1273–84. Available from: https://doi.org/10.1006/jmbi.1999.3238
Davies J, Shringarpure R, Grune T. Ubiquitin conjugation is not required for the degradation of oxidized proteins by the proteasome. J Biol Chem. 2003 Jan 3;278(1):311–8. Available from: https://doi.org/10.1074/jbc.m206279200
Michielsen E, Diris C, Wodzig W, Dieijen-Visser M. Highly sensitive immunoprecipitation method for extracting and concentrating low-abundance proteins from human serum. Clin Chem. 2005 Jan;51(1):222–4. Available from: https://doi.org/10.1373/clinchem.2004.036251
Sisson T, Castor W. An improved method for immobilizing IgG antibodies on protein A-agarose. J Immunol Methods. 1990;127(2):215–20. Available from: https://doi.org/10.1016/0022-1759(90)90071-3
Levine R, Garland D, Oliver C, Amici A, Climent I, Stadtman E. Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol. 1990;186:464–78. Available from: https://doi.org/10.1016/0076-6879(90)86141-h
Levine R, Williams J, Stadtman E, Shacter E. Carbonyl assays for determination of oxidatively modified proteins. Methods Enzymol. 1994;233:346–57. Available from: https://doi.org/10.1016/s0076-6879(94)33040-9
Reznick A, Packer L. Oxidative damage to proteins: Spectrophotometric method for carbonyl assay. Methods Enzymol. 1994;233:357–63. Available from: https://doi.org/10.1016/s0076-6879(94)33041-7
Shacter E. Protein oxidative damage. Methods Enzymol. 2000;319:428–36. Available from: https://doi.org/10.1016/s0076-6879(00)19040-8
Houglum K, Ramm G, Powell L, Chojkier M. Excess iron induces hepatic oxidative stress and transforming growth factor β1 in genetic hemochromatosis. Hepatology. 1997;26(3):605–10. Available from: https://doi.org/10.1002/hep.510260311
Dalle-Donne I, Rossi R, Gagliano N, Milzani A. Protein carbonylation in human diseases. Trends Mol Med. 2003;9(4):169–76. Available from: https://doi.org/10.1016/s1471-4914(03)00031-5
Aust S, Morehouse L, Thomas C. Role of metals in radical oxygen reactions. J Free Radic Biol Med. 1985;1(1):3–25. Available from: https://doi.org/10.1016/0748-5514(85)90025-x
Headlam H, Davies J. Markers of protein oxidation: Different oxidants give rise to variable yields of bound and released carbonyl products. Free Radic Biol Med. 2004;36(9):1175–84. Available from: https://doi.org/10.1016/j.freeradbiomed.2004.02.017
Bates G, Schlabach M. The reaction of ferric salts with transferrin. J Biol Chem. 1973;248(9):3228–32. Available from: https://pubmed.ncbi.nlm.nih.gov/4735577/
Bacon BR, Tavill AS, Park CH. Hepatic lipid peroxidation In vivo in rats with chronic iron overload. J Clin Invest. 1983;71(2):429–39. Available from: https://doi.org/10.1172/jci110787
McCord M, Day E. Superoxide-dependent production of hydroxyl radical catalyzed by the iron-EDTA complex. FEBS Lett. 1978;86(1):139–42. Available from: https://doi.org/10.1016/0014-5793(78)80116-1
Baldwin D, Jenny E, Aisen P. The effect of human serum transferrin and milk lactoferrin on hydroxyl radical formation from superoxide and hydrogen peroxide. J Biol Chem. 1984;259(20):13391–4. Available from: https://pubmed.ncbi.nlm.nih.gov/6092375/
Halliwell B, Gutteridge J. The importance of free radicals and catalytic metal ions in human diseases. Mol Aspects Med. 1985;8(2):89–193. Available from: https://doi.org/10.1016/0098-2997(85)90001-9
Alexander J, Kowdley KV. HFE-associated hereditary hemochromatosis. Genet Med. 2009;11(5):307–13. Available from: https://doi.org/10.1097/gim.0b013e31819d30f2
Aisen P. Transferrins, the transferrin receptor, and the uptake of iron by cells. In: Sigel A, Sigel H, editors. Metal Ions in Biological Systems. Vol. 23. New York: Marcel Dekker; 1998. p. 585–631. Available from: https://pubmed.ncbi.nlm.nih.gov/9444770/
Thevis M, Ogorzalek Loo R, Loo JA. Mass spectrometric characterization of transferrins and their fragments derived by reduction of disulfide bonds. J Am Soc Mass Spectrom. 2003;14(6):635–47. Available from: https://doi.org/10.1016/s1044-0305(03)00199-5
Van Campenhout A, Van Campenhout CM, Keenoy B. Transferrin modification and lipid peroxidation: Implications in diabetes mellitus. Free Radic Res. 2003;37(10):1069–77. Available from: https://doi.org/10.1080/10715760310001600390
Reynolds L, Klein M. Iron poisoning – A preventable hazard of childhood. S Afr Med J. 1985;67(18):680–3. Available from: https://pubmed.ncbi.nlm.nih.gov/3992389/